Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Randomized Placebo-controlled Multicenter Study to Evaluate Clinical Efficacy and Safety of Ingavirin®, Capsules 30 mg, in 3-6 Years Old Patients With Influenza and Other Acute Respiratory Viral Infections in the Course of Standard Therapy

NCT02644018 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT02644018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Randomized Placebo-controlled Multicenter Study to Evaluate Clinical Efficacy and Safety of Ingavirin®, Capsules 30 mg, in 3-6 Years Old Patients With Influenza and Other Acute Respiratory Viral Infections in the Course of Standard Therapy
Lead sponsor
Valenta Pharm JSC
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2016
Completion date
May 31, 2016
Enrollment
190 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, influenza